Sumner Michael John 4
4 · INOVIO PHARMACEUTICALS, INC. · Filed Dec 18, 2024
Insider Transaction Report
Form 4
Sumner Michael John
Chief Medical Officer
Transactions
- Award
Common Stock Option
2024-12-18+5,708→ 5,708 totalExercise: $1.78Exp: 2034-12-18→ Common Stock (5,708 underlying) - Award
Restricted Stock Unit
2024-12-18+4,292→ 4,292 total→ Common Stock (4,292 underlying)
Footnotes (2)
- [F1]Options to vest 100% on March 31, 2026, subject to the reporting person's continuous service with the issuer through such date.
- [F2]Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on March 31, 2026, subject to the reporting person's continuous service with the issuer through such date.